ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy
Ann Surg Oncol
.
2021 Jul;28(7):3808-3809.
doi: 10.1245/s10434-020-09487-2.
Epub 2021 Jan 21.
Authors
Mohamed Abdelgadir Adam
1
,
Alessandro Paniccia
2
Affiliations
1
Division of Liver, Biliary, and Pancreatic Surgery, University of California, San Francisco, CA, USA. mohamed.adam@ucsf.edu.
2
Division of Surgical Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
PMID:
33475885
DOI:
10.1245/s10434-020-09487-2
No abstract available
MeSH terms
Adenocarcinoma* / drug therapy
Chemotherapy, Adjuvant
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms* / drug therapy